Up to 45% of the trial costs for the dose-determining Phase 1b trial will be fun...
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharm...
The UK MHRA has granted marketing authorisation for AbbVie’s Aquipta (atogepant)...
The Chinese NMPA approved for AstraZeneca’s Calquence to treat chronic lymphocyt...
Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergene...
Digital information exchange can be safer, cheaper and more environmentally frie...
In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University resea...
IOP Publishing (IOPP) has appointed Dr. David Gevaux as the first Chief Editor o...
The severe global threat posed by invasive alien species is underappreciated, un...
In a review published in Engineering, scientists explore the burgeoning field of...
Around 5.2% of the global population carries abnormal hemoglobin genes [1]. Each...
Halle/Saale, Fort Lauderdale. More than 100 years of observations in nature have...
Humana sued the federal government Friday over a rule that claws back overpaymen...
Residents of disadvantaged neighborhoods were far more likely to be allocated a ...
The FTC had challenged the deal over concerns the combined company could abuse i...
